Antibiotic prophylaxis to prevent surgical site infections

American Family Physician

Volumn 83, Issue 5, 2011, Pages 585-590

  Salkind, Alan R ^a   Rao, Kavitha C ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; CEFAZOLIN; CEFOTETAN; CEFOXITIN; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; GENTAMICIN; LEVOFLOXACIN; METRONIDAZOLE; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL EFFECTIVENESS; DOSE RESPONSE; DRUG CHOICE; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; HUMAN; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; RECOMMENDED DRUG DOSE; SINGLE DRUG DOSE; SURGICAL INFECTION; THORAX SURGERY; TREATMENT DURATION; METHODOLOGY; REVIEW;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; HUMANS; SURGICAL WOUND INFECTION; VANCOMYCIN;

EID: 79955951814     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Horan TC, Gaynes RP, Martone WJ, et al. CDC defnitions of nosocomial surgical site infections, 1992: a modifca-tion of CDC defnitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13(10):606-608.
2. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20(4):250-278.
3. Perencevich EN, Sands KE, Cosgrove SE, et al. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis. 2003; 9(2):196-203.
4. Whitehouse JD, Friedman ND, Kirkland KB, et al. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol. 2002;23(4): 183-189.
5. Martone WJ, Nichols RL. Recognition, prevention, surveillance, and management of surgical site infections: introduction to the problem and symposium overview. Clin Infect Dis. 2001;33(suppl 2):S67-S68.
6. Kirkland KB, Briggs JP, Trivette SL, et al. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999;20(11):725-730.
7. Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis. 2006;43(3):322-330.
8. Antimicrobial prophylaxis for surgery. Treat Guidel Med Lett. 2009;7(82):47-52.
9. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg. 2005;189 (4):395-404.
10. Stulberg JJ, Delaney CP, Neuhauser DV, et al. Adherence to surgical care improvement project measures and the association with postoperative infections. JAMA. 2010;303(24):2479-2485.
11. Classen DC, Evans RS, Pestotnik SL, et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med. 1992; 326(5):281-286.
12. van Kasteren ME, Manniën J, Ott A, et al. Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor. Clin Infect Dis. 2007;44(7):921-927.
13. Steinberg JP, Braun BI, Hellinger WC, et al. Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors. Ann Surg. 2009;250(1):10-16.
14. Shojania KG, Duncan BW, McDonald KM, et al., eds. Making health care safer. A critical analysis of patient safety practices. Rockville, Md.: Agency for Healthcare Research and Quality; 2001. AHRQ publication no. 01-E058.
15. Bratzler DW, Houck PM, Richards C, et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg. 2005;140(2):174-182.
16. Brown J, Doloresco F III, Mylotte JM. "Never events": not every hospital-acquired infection is preventable. Clin Infect Dis. 2009;49(5):743-746.
17. American Academy of Family Physicians. Facts about family medicine. http://www.aafp.org/online/en/home/aboutus/specialty/facts.html. Accessed March 18, 2010.
18. Barker FG. Effcacy of prophylactic antibiotic therapy in spinal surgery: a meta-analysis. Neurosurgery. 2002;51(2):391-400.
19. McDonald M, Grabsch E, Marshall C, et al. Single-versus multiple-dose antimicrobial prophylaxis for major surgery. Aust N Z J Surg. 1998;68(6):388-396.
20. Slobogean GP, Kennedy SA, Davidson D, et al. Single-versus multiple-dose antibiotic prophylaxis in the surgical treatment of closed fractures: a meta-analysis. J Orthop Trauma. 2008;22(4):264-269.
21. Bosco JA, Slover JD, Haas JP. Perioperative strategies for decreasing infection: a comprehensive evidence-based approach. J Bone Joint Surg Am. 2010;92(1): 232-239.
22. Zanetti G, Giardina R, Platt R. Intraoperative redosing of cefazolin and risk for surgical site infection in cardiac surgery. Emerg Infect Dis. 2001;7(5):828-831.
23. Zelenitsky SA, Ariano RE, Harding GK, et al. Antibiotic pharmacodynamics in surgical prophylaxis: an association between intraoperative antibiotic concentrations and effcacy. Antimicrob Agents Chemother. 2002;46(9):3026-3030.
24. Wenzel RP, Reagan DR, Bertino JS, et al. Methicillin-resistant Staphylococcus aureus outbreak: a consensus panel's defnition and management guidelines. Am J Infect Control. 1998;26(2):102-110.
25. Bolon MK, Morlote M, Weber SG, et al. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin Infect Dis. 2004;38(10):1357-1363.
26. Finkelstein R, Rabino G, Mashiah T, et al. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg. 2002;123(2):326-332.
27. Manian FA, Meyer PL, Setzer J, et al. Surgical site infections associated with methicillin-resistant Staphylococ-cus aureus: do postoperative factors play a role? Clin Infect Dis. 2003;36(7):863-868.
28. Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of Staphylo-coccus aureus. N Engl J Med. 2010;362(1):9-17.
29. van Rijen M, Bonten M, Wenzel R, et al. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev. 2008;(4):CD006216.
30. Harbarth S, Fankhauser C, Schrenzel J, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA. 2008;299(10):1149-1157.
31. Engelman R, Shahian D, Shemin R, et al.; Workforce on Evidence-Based Medicine. The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part II: antibiotic choice. Ann Thorac Surg. 2007;83(4):1569-1576.
32. Evans RP; American Academy of Orthopaedic Surgeons Patient Safety Committee. Surgical site infection prevention and control: an emerging paradigm. J Bone Joint Surg Am. 2009;91(suppl 6):2-9.
33. Daum RS. Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus [published correction appears in N Engl J Med. 2007;357(13):1357]. N Engl J Med. 2007;357(4): 380-390.
34. Mohri Y, Tonouchi H, Kobayashi M, et al.; Mie Surgical Infection Research Group. Randomized clinical trial of single- versus multiple-dose antimicrobial prophylaxis in gastric cancer surgery. Br J Surg. 2007;94(6):683-688.
35. Edwards FH, Engelman RM, Houck P, et al. The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part I: duration. Ann Thorac Surg. 2006;81(1):397-404.
36. Ortega GM, Martí-Bonmatí E, Guevara SJ, et al. Alteration of vancomycin pharmacokinetics during cardiopul-monary bypass in patients undergoing cardiac surgery. Am J Health Syst Pharm. 2003;60(3):260-265.
37. Harbarth S, Samore MH, Lichtenberg D, et al. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation. 2000;101(25):2916-2921.
38. de Oliveira JC, Martinelli M, Nishioka SA, et al. Eff-cacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defbrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial [published correction appears in Circ Arrhythm Electrophysiol. 2009;2(1):e1]. Circ Arrhythm Electrophysiol. 2009;2(1):29-34.
39. Tejwani NC, Immerman I. Myths and legends in orthopaedic practice: are we all guilty? Clin Orthop Relat Res. 2008;466(11):2861-2872.
40. Parry GW, Holden SR, Shabbo FP. Antibiotic prophylaxis for cardiac surgery. Br Heart J. 1993;70(6):585-586.